Severe hypoglycemia (SH) is one of the most critical acute complications of insulin treatment, especially in young patients who may have a limited ability to recognize hypoglycemic symptoms and exhibit who may have limited ability to recognize hypoglycemic symptoms and experience fluctuations in insulin sensitivity due to growth, hormonal changes, and variable metabolic demands. The gene discussed is INS; the disease is Hypoglycemia.